Jun 1, 2016 · Our study shows no significant outcome differences in patients younger than 50 years receiving reduced-intensity myeloablative conditioning regimens after ...
Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for ...
Mar 2, 2016 · Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor ...
Our study shows no significant outcome differences in patients younger than 50 years receiving reduced-intensity vs myeloablative conditioning regimens after ...
Our study shows no significant outcome differences in patients younger than 50 years receiving reduced-intensity vs myeloablative conditioning regimens after ...
Jul 26, 2020 · Reduced-intensity conditioning provided comparable results to myeloablative conditioning for patients with acute myeloid leukemia (AML) aged 40 to 60 years.
May 2, 2024 · Allogeneic stem cell transplantation (alloSCT) represents a potentially curative treatment for patients suffering from acute myeloid leukemia ( ...
Missing: Expanding | Show results with:Expanding
Our study shows no significant outcome differences in patients younger than 50 years receiving reduced-intensity vs myeloablative conditioning regimens after ...
Allogeneic HCT offers a survival benefit in patients with intermediate- and high-risk AML and is currently a part of standard clinical care.
Myeloablative conditioning (MAC) results in lower relapse and better disease-free survival (DFS) after hematopoietic cell transplantation for acute myelogenous ...